Navigation Links
High-sensitivity bone marrow aspiration technology enhances leukemia cell detection
Date:10/6/2009

PHILADELPHIA Scientists have created a viable technology to improve the detection of leukemia cells in bone marrow.

Superconducting Quantum Interference Device (SQUID) enhanced the ability to rapidly quantify the amount of nanoparticle bound tumor cells in a sample at least 10 fold, and increased sensitivity of minimal residual disease measurements. Results of this proof-of-concept study are published in Cancer Research, a journal of the American Association for Cancer Research.

"This promises to significantly enhance the detection for residual disease in leukemia and other cancers," said lead scientist Richard S. Larson, M.D., Ph.D., vice president for translation research at the University of New Mexico Health Science Center. "Coupling nanotechnology can be employed in common techniques to enhance its utility."

These findings are a result of a collaborative research effort between Senior Scientific, LLC, and the University of New Mexico. The study was funded by a small business innovation grant awarded by the National Cancer Institute.

Previous studies have indicated that the magnetic needle can collect approximately 80 percent of leukemia cells in a bone marrow sample in a matter of minutes, according to Edward R. Flynn, Ph.D., president and CEO of Senior Scientific, LLC.

The scientists developed this magnetic marrow biopsy needle in an effort to target tumor cells with nanoparticles and then preferentially extract the tumor cells with a magnetic needle. They used anti-CD34 antibody loaded magnetic nanoparticles to detect CD34+ cells as an indicator of leukemia. To quantify the cells recovered, they coupled this nanoparticle-mediated fishing for leukemic cells with SQUID.

SQUID enhanced the sensitivity of measuring minimal residual disease over standard pathology methods for patients undergoing chemotherapy.

"This result will determine more precisely the effect of the chemotherapy a
'/>"/>

Contact: Tara Yates
tara.yates@aacr.org
267-646-0558
American Association for Cancer Research
Source:Eurekalert  

Page: 1 2

Related medicine news :

1. Van Andel Institute researchers find gene that could lead to new therapies for bone marrow disease
2. Save a Life: Join the Kiel Mortgage Marrow-thon on September 23
3. Help Save a Life - Bone Marrow Donor Registry Drive Sept. 2 at the Karmanos Cancer Center
4. ThermoGenesis Announces Launch of Res-Q System; New Device Expands Companys Presence in Bone Marrow Sector
5. Cerebral Palsy Improves After Bone Marrow Stem Cell Procedure
6. Ready for relapse: Molecule helps breast cancer cells to survive in the bone marrow
7. Trimming the fat boosts blood recovery after marrow transplant
8. National Marrowthon Campaign Aims to Bring Nearly 50,000 to the Be The Match Registry(SM) in Two Weeks
9. Weber Shandwick Chosen By National Marrow Donor Program(R) To Head Awareness Campaign
10. Bone marrow stem cell co-transplantation prevents embryonic stem cell transplant-associated tumors
11. Bone Marrow Registry to Launch Groundbreaking Fundraising Technology to Overcome Madoff Crisis

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
High-sensitivity bone marrow aspiration technology enhances leukemia cell detection
High-sensitivity bone marrow aspiration technology enhances leukemia cell detection
(Date:11/27/2009)... Multi-purpose bilingual coloring books d...e by the business community to educate - inform pa...from Safety issues to Dinosuars to ABC,S and a hos...t Louis, MO (PRWEB) November 27, 2009 -- Today&rsq...toys to keep them busy any hour of the day, but on...
(Date:11/26/2009)...INCETON, N.J., Nov. 27 The diabete...le over the next 25 years and annual medical spend...n, up from $113 billion today, according to a stud...e . The National Changing Diabetes ® Progra...the analysis by a team from the University of Chic...
(Date:11/26/2009)...r thrill when on an emotional rollercoaster, study...News) -- Call it the fear factor meets the jubilan...ators -- especially those who root for the winning... closely contested match and victory was in doubt,..., Chew on that this Thanksgiving weekend as you,re...
(Date:11/26/2009)... Benton Communications announces a highly...em for retailers struggling to make an economic re...r 26, 2009 -- Flu fears is the type of challenge t...cy room, according to Dr. David Benton, business g...ness growth system – The Rfactor Intensive ...
(Date:11/25/2009)...ERYVILLE, Calif., Nov. 25 /PRNewswire-FirstCall/ -...day announced that the company will host two inves..., December 7, 2009 - 9:00 a.m. CT/10:00 a.m. E...a presentations surrounding carfilzomib in relapse...at the 51st American Society of Hematology (ASH) A...
Breaking Medicine News(10 mins):Health News:Really Big Coloring Books Debuts Bi-Lingual Spanish-English Line of Custom and Imprintable Coloring Books 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 3Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 4Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3Health News:Pharmacist Injects Cure for Ailing Businesses 2Health News:Onyx Pharmaceuticals Announces December 2009 Investor Events 2
... for expectant moms to drink, study says , ...ements may help mothers-to-be reduce the risk for ...ancy, Australian researchers report. , The study, ...amage to the fetus depends not only on the amount ...
...ng statement of Matthew L. Myers, President, Campa..., (Logo: http://www.newscom.com/cgi-bin/prnh/2008...gislation announced today in Virginia fails to pro...stead enact a comprehensive, statewide smoke-free ...
...Net Development Group, Inc. (the "Company") (Nasd...opment services, today announced that it will rele...l results on Wednesday, February 25, 2009, after m...provides a comprehensive range of services to the ...
... letter sent today to the U.S. Senate Leadership a...inance Committee, the Coalition to Protect Senior ...nt to the pending economic stimulus bill, S.1. The...ty standards, or reduces provider payments -- whic...
...ng is a statement by ADA President John S. Findley...eps. Bart Stupak (D-Mich.) and Candice Miller (R-M...der Act, (H.R. 903), a bill that would bolster Ame...he nation,s dentists. , , "This legislation, whic...
...ursesbooks.org, the publishing program of American...ternational Society of Nurses in Genetics has just...llenges associated with advances in genetics tech...cutting edge of understanding the causal factors o...
Other Medicine News:Health News:Zinc May Counter Effects of Alcohol in Early Pregnancy 2Health News:Virginia Leaders Should Reject Flawed Smoke-Free Legislation That Fails to Protect Everyone's Right to Breathe Clean Air 2Health News:PharmaNet Development Group, Inc. to Announce Fourth Quarter and Full Year 2008 Financial Results on February 25, 2009 2Health News:PharmaNet Development Group, Inc. to Announce Fourth Quarter and Full Year 2008 Financial Results on February 25, 2009 3Health News:PharmaNet Development Group, Inc. to Announce Fourth Quarter and Full Year 2008 Financial Results on February 25, 2009 4Health News:National Front Line Caregiver Group Urges Senate Leaders to Support Grassley Amendment Protecting Seniors' Care, Assuring Stability of Nation's Long Term Care Workforce 2Health News:Statement by ADA President John S. Findley on the Dental Emergency Responder Act Introduced Today by Reps. Stupak and Miller 2Health News:ANA and ISONG Co-Publish Genetics and Ethics in Health Care: New Questions in the Age of Genomic Health 2Health News:ANA and ISONG Co-Publish Genetics and Ethics in Health Care: New Questions in the Age of Genomic Health 3
(Date:11/25/2009)... Mass., Nov. 25 According to Mille...n medical technology market intelligence, the near...s will continue to see rapid growth over the next ...RG,s US Markets for Trauma Devices 2010 report... over the next five years, with competitors introd...
(Date:11/25/2009)...ewswire/--Reportlinker.comannouncesthatanewmarketr...ranasalDrugDelivery-USMarketTrends&Analysis h...g-Delivery---US-Market-Trends--Analysis.html ,...xpansionoftherapeuticapplicationsfromthedeliveryof...stemictherapeuticdrugs.Thefutureofthetechnologyhin...
(Date:11/24/2009)...SDA, Md., Nov. 24 /PRNewswire-Asia/ -- Chindex Int...eading independent American provider of Western,he...ublic of China, today,announced that the Company w...d" Health Care Conference, to be held December 1 -... Management is currently scheduled to present at 1...
Breaking Medicine Technology:US Trauma Fixation Device Market Not Seeing Signs of Slowdown 2US Trauma Fixation Device Market Not Seeing Signs of Slowdown 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5Chindex International to Present at Piper Jaffray Health Care Conference 2ProDrive Systems Announces Exclusive Distribution Agreement with Patterson Dental Canada 56087 1ProDrive Systems Announces Exclusive Distribution Agreement with Patterson Dental Canada 56087 2Detroit Clinic Manager Pleads Guilty in Medicare Fraud Scheme 56084 1Detroit Clinic Manager Pleads Guilty in Medicare Fraud Scheme 56084 2Detroit Clinic Manager Pleads Guilty in Medicare Fraud Scheme 56084 3Martek Announces Third Quarter 2009 Financial Results 56082 1Martek Announces Third Quarter 2009 Financial Results 56082 2Martek Announces Third Quarter 2009 Financial Results 56082 3Martek Announces Third Quarter 2009 Financial Results 56082 4Martek Announces Third Quarter 2009 Financial Results 56082 5Martek Announces Third Quarter 2009 Financial Results 56082 6Martek Announces Third Quarter 2009 Financial Results 56082 7Martek Announces Third Quarter 2009 Financial Results 56082 8Martek Announces Third Quarter 2009 Financial Results 56082 9Martek Announces Third Quarter 2009 Financial Results 56082 10Martek Announces Third Quarter 2009 Financial Results 56082 11Martek Announces Third Quarter 2009 Financial Results 56082 12
...ted Improvement in Symptoms Both in the Short and ...LMINGTON, Del., May 5 AstraZeneca (NYSE:,AZN) tod...etiapine,fumarate) Extended-Release Tablets for th... generalized anxiety disorder (GAD) in adult patie...oday at the 161st Annual,Meeting of the American P...
...May 5 N30 Pharma (N30), a,biopharmaceutical compa...ercialization of drugs that target endogenous s-ni...ly completed Phase I study of N30-201,in patients ...olunteers.,N30 intends to develop N30-201 for the ...ses, including Cystic Fibrosis and asthma., "We a...
Other Medicine Technology:New Data on SEROQUEL XR(TM) in Treatment of Both Major Depressive Disorder and Generalized Anxiety Disorder Presented at APA Annual Meeting 2New Data on SEROQUEL XR(TM) in Treatment of Both Major Depressive Disorder and Generalized Anxiety Disorder Presented at APA Annual Meeting 3New Data on SEROQUEL XR(TM) in Treatment of Both Major Depressive Disorder and Generalized Anxiety Disorder Presented at APA Annual Meeting 4New Data on SEROQUEL XR(TM) in Treatment of Both Major Depressive Disorder and Generalized Anxiety Disorder Presented at APA Annual Meeting 5New Data on SEROQUEL XR(TM) in Treatment of Both Major Depressive Disorder and Generalized Anxiety Disorder Presented at APA Annual Meeting 6New Data on SEROQUEL XR(TM) in Treatment of Both Major Depressive Disorder and Generalized Anxiety Disorder Presented at APA Annual Meeting 7New Data on SEROQUEL XR(TM) in Treatment of Both Major Depressive Disorder and Generalized Anxiety Disorder Presented at APA Annual Meeting 8New Data on SEROQUEL XR(TM) in Treatment of Both Major Depressive Disorder and Generalized Anxiety Disorder Presented at APA Annual Meeting 9New Data on SEROQUEL XR(TM) in Treatment of Both Major Depressive Disorder and Generalized Anxiety Disorder Presented at APA Annual Meeting 10New Data on SEROQUEL XR(TM) in Treatment of Both Major Depressive Disorder and Generalized Anxiety Disorder Presented at APA Annual Meeting 11New Data on SEROQUEL XR(TM) in Treatment of Both Major Depressive Disorder and Generalized Anxiety Disorder Presented at APA Annual Meeting 12New Data on SEROQUEL XR(TM) in Treatment of Both Major Depressive Disorder and Generalized Anxiety Disorder Presented at APA Annual Meeting 13New Data on SEROQUEL XR(TM) in Treatment of Both Major Depressive Disorder and Generalized Anxiety Disorder Presented at APA Annual Meeting 14N30 Pharma Announces Completion of Phase 1 Clinical Studies With N30-201 2
Disposable Hitachi Needle Template
MicroTouch LP (Low Profile) Stabilizer
...gital stepper designed to interface with Interplan...nning. ,Digital registration in treatment planni...ent, and template location for precise planning ,...udy time ,1mm image acquisition for enhanced pro...
...YAG laser system with a wavelength of 1,064 nm. MY...s well as red and blue vein irregularities. MYDON ... darker skin types (1 to 6) and with fine hair as ...he handpieces special design ensures effective coo...
Medicine Products: